<DOC>
	<DOCNO>NCT02684825</DOCNO>
	<brief_summary>The primary objective study evaluate whether , patient first-ever atherothrombotic lacunar stroke without previous history atrial fibrillation ( AF ) /atrial flutter ( AFL ) /atrial tachycardia ( AT ) , detection AF/AFL/AT ( silent symptomatic ) use continuous cardiac rhythm monitoring implantable loop recorder ( ILR ) first 12 month observation high detection use standard cardiac monitoring ( physical exam , 12-lead electrocardiogram [ ECG ] baseline , 3 , 6 , 12 month Holter ECG 3 month ) period time .</brief_summary>
	<brief_title>Detection Silent Atrial Fibrillation aFter Ischemic StrOke</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) associate high risk stroke prevalence increase subject age ≥65 year . After ischemic stroke , use standard monitoring method may underestimate detection rate AF . Recent study demonstrate fourfold sixfold increase detection AF prolong ECG monitoring compare standard cardiac monitoring patient cryptogenic stroke . Hence , likely even patient first atherothrombotic lacunar stroke high burden vascular risk factor expose increase risk develop AF subsequent year AF may cause underlie possible recurrent stroke . SAFFO trial objective evaluate detection AF atrial flutter ( AFL ) first diagnosis implantable loop recorder ( ILR ) patient first-ever atherothrombotic lacunar stroke . Patients recent ( 30-60 day symptom onset ) diagnosis first-ever atherothrombotic lacunar ischemic stroke fulfill inclusion criterion randomize either continuous cardiac monitoring use ILR plus standard cardiac monitoring ( intervention arm ) standard cardiac monitoring alone ( control arm ) ratio 1:1 . The hypothesis detection AF/AFL use ILR high observe use standard cardiac monitoring . Secondary tertiary objective study include exploratory analysis incidence recurrent stroke different stroke subtypes reduction stroke risk death cause study patient , two randomization group , particular , patient treat antiplatelet therapy versus treat oral anticoagulant ( OAC ) therapy , latter implement guided detection clinically meaningful episode AF/AFL/AT use ILR compare standard cardiac monitoring . Moreover , study objective evaluate clinical , neuroimaging , echocardiographic profile predictive AF/AFL/AT first diagnosis stroke recurrence . SAFFO prospective , multicenter , randomize , control , open-label trial blind assessment outcome measure . Diagnosis atherothrombotic lacunar etiology define accord TOAST ( trial ORG 10172 acute stroke treatment ) / CCS ( Causative Classification System ischemic stroke ) classification criterion standard diagnostic protocol fulfil randomization ( medical history ; risk factor ; symptom ; cerebral magnetic resonance [ MR ] and/or CT ; 12-lead ECG and/or Holter ECG and/or standard heart rhythm monitoring procedure ; transthoracic and/or transoesophageal echocardiogram ; intra- extracranial vessel ultrasonography and/or CT-Angiography and/or MR- Angiography , also order rule non-atherosclerotic vasculopathies ; thrombophilic/hematologic screen hypercoagulability state hematologic disorder suspect ) . ILR ( Medtronic Reveal LINQTM- LNQ11REVEAL LinQ ) implantation perform within 8 day randomization allow continuous monitor single-lead ECG registration 3 year . Standard cardiac rhythm monitoring include : detail data collection possible patient 's symptom suggestive AF/AFL/AT , physical exam include cardiovascular examination , 12-lead ECG , 24-hour Holter ECG perform 3-month follow-up visit . If positive , SAFFO trial could important clinical implication term change standard diagnostic protocol patient atherothrombotic lacunar stroke , increase shift secondary prevention treatment antiplatelet anticoagulant therapy indicate .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Central Nervous System Diseases</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Brain Infarction</mesh_term>
	<criteria>Age ≥65 year . Recent ( 3060 day symptom onset ) diagnosis firstever ischemic stroke . Ischemic stroke defined event characterize sudden onset acute focal neurological symptom , MR CT finding consistent ischemic stroke , evidence neurological disorder clinically radiographically explain . Patients reversible neurological deficit within 24 hour ( clinical TIA ) , cerebral injury ischemic origin visible neuroimages correspond patient symptom , classify ischemic stroke consider study . Diagnosis atherothrombotic lacunar etiology , define accord TOAST classification criterion standard diagnostic protocol fulfil randomization ( medical history ; risk factor ; symptom ; cerebral MR and/or CT ; 12lead ECG and/or Holter ECG and/or standard heart rhythm monitoring procedure ; transthoracic and/or transoesophageal echocardiogram ; intra extracranial vessel ultrasonography and/or CTAngiography and/or MRAngiography , also order rule nonatherosclerotic vasculopathies ; thrombophilic/hematologic screen hypercoagulability state hematologic disorder suspect ) . Presence least one follow risk factor : hypertension ; diabetes ; vascular disease ( previous myocardial infarction , peripheral arteriopathy ) . Neurological severity term functional dependency define mRS ( modify Rankin Scale ) score ≤3 . Written informed consent . TIA without evidence cerebral infarction neuroimaging correspond patient symptom . Diagnosis cardioembolic stroke base medical history cerebral/cardiological/vascular diagnostic evaluation ( e.g. , evidence highrisk emboligenic source heart aortic arch : left ventricle atrium thrombus `` smoke '' , emboligenic valvular lesion , emboligenic tumor , patent foramen ovale [ PFO ] associate possible venous thromboembolic source hence eligible oral anticoagulant [ OAC ] therapy , aortic arch plaque &gt; 3 mm thickness contain mobile component , highrisk embolic lesion ) . Diagnosis ischemic stroke different etiopathogenesis , example due nonatherosclerotic vasculopathies , hypercoagulability state ( diagnose thrombophilic screen ) hematologic disorder ; diagnosis cryptogenic stroke . Previous documented history atrial fibrillation ( AF ) atrial flutter ( AFL ) History untreated hyperthyroidism History myocardial infarction &lt; 1 month study screen visit Valvular disease require immediate surgical intervention Recent ( &lt; 6 month study screen visit ) cardiac surgery Other condition associate increase risk AF : sick sinus syndrome , recent ( &lt; 14 day study Screening visit ) surgery ; current infection Permanent indication anticoagulation Contraindications OAC therapy Stroke associate severe functional disability define mRS &gt; 3 Hear failure associate severe ventricular dysfunction ejection fraction ≤40 % Indication pacemaker defibrillator implant Any condition , opinion investigator , could make non feasible hazardous patient 's participation study condition could compromise completion patient 's participation term followup visit ( example , diseases associated poor prognosis life expectancy &lt; 1 year ) . Severe renal failure liver disease Participation clinical trial interfere objective study Poor patient 's compliance could compromise his/her correct participation study Patient 's refusal give his/her inform consent participation study .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Stroke</keyword>
	<keyword>ischemic stroke</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>continuous cardiac monitoring</keyword>
	<keyword>insertable cardiac monitoring</keyword>
	<keyword>implantable loop recorder</keyword>
	<keyword>antithrombotics</keyword>
	<keyword>anticoagulant</keyword>
	<keyword>stroke subtype</keyword>
	<keyword>atherothrombotic stroke</keyword>
	<keyword>lacunar stroke</keyword>
</DOC>